Mre11-dependent degradation of stalled DNA replication forks is prevented by BRCA2 and PARP1

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• PARP inhibitors are investigated for BRCA1/2-defective tumors due to synthetic lethality with homologous recombination (HR).
• The precise molecular mechanisms underlying this synthetic lethality are not fully understood.

Purpose of the Study:

• To investigate the role of Mre11 in BRCA2-deficient cells and its interaction with PARP1 in protecting stalled replication forks.
• To elucidate the molecular mechanisms driving synthetic lethality between BRCA2 and PARP1.

Main Methods:

• Assessed Mre11 levels and resection at stalled replication forks in BRCA2-deficient cells.
• Evaluated hypersensitivity of BRCA2-deficient cells to the Mre11 inhibitor mirin.
• Investigated the requirement of PARP1 activity for protecting stalled forks from Mre11-dependent degradation.
• Analyzed Mre11 foci and mirin sensitivity in BRCA2-mutant cells resistant to PARP inhibition.

Main Results:

• BRCA2-deficient cells exhibited increased Mre11 levels and enhanced resection at stalled replication forks.
• These cells were hypersensitive to the Mre11 inhibitor mirin.
• PARP1 activity was essential for preventing Mre11-dependent degradation of stalled forks.
• Resistance to PARP inhibition in BRCA2-mutant cells correlated with reduced Mre11 foci and mirin sensitivity.

Conclusions:

• Mre11 activity is essential for the survival of BRCA2-mutant cells.
• BRCA2 and PARP1 play critical roles in protecting stalled replication forks.
• These findings provide insight into the molecular basis of synthetic lethality between BRCA2 and PARP1, relevant for cancer therapy.